NYSE:THC - Tenet Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $92.38
  • Forecasted Upside: 38.93 %
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 13 Buy Ratings
  • 1 Strong Buy Ratings
$66.49
▲ +0.85 (1.29%)

This chart shows the closing price for THC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tenet Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THC

Analyst Price Target is $92.38
▲ +38.93% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $92.38, with a high forecast of $125.00 and a low forecast of $73.00. The average price target represents a 38.93% upside from the last price of $66.49.

This chart shows the closing price for THC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 15 polled investment analysts is to buy stock in Tenet Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 1 sell ratings
2/17/2021
  • 1 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 1 sell ratings
5/18/2021
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 1 sell ratings
8/16/2021
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/14/2021
  • 1 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/12/2022
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/13/2022
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/12/2022
  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/11/2022

Latest Recommendations

  • 1 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/2/2022MizuhoBoost Price TargetBuy$63.00 ➝ $80.00Low
7/29/2022Wells Fargo & CompanyLower Price Target$90.00 ➝ $82.00Low
7/28/2022UBS GroupLower Price TargetBuy$113.00 ➝ $91.00Low
7/25/2022StephensBoost Price Target$73.00Low
7/25/2022Truist FinancialBoost Price TargetBuy$75.00 ➝ $80.00Low
7/25/2022SVB LeerinkBoost Price TargetOutperform$68.00 ➝ $88.00Low
7/25/2022CitigroupLower Price TargetBuy$110.00 ➝ $99.00Low
7/24/2022Bank of AmericaBoost Price Target$70.00 ➝ $75.00Low
7/19/2022Credit Suisse GroupSet Price Target$104.00Low
7/15/2022SVB LeerinkLower Price TargetOutperform$110.00 ➝ $68.00Low
7/12/2022The Goldman Sachs GroupLower Price TargetBuy$108.00 ➝ $93.00N/A
7/11/2022Raymond JamesLower Price TargetStrong-Buy$120.00 ➝ $110.00N/A
7/7/2022Deutsche Bank AktiengesellschaftLower Price TargetBuy$110.00 ➝ $90.00N/A
7/1/2022MizuhoLower Price TargetBuy$103.00 ➝ $63.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$80.00Low
4/25/2022Wells Fargo & CompanyLower Price TargetOverweight$100.00 ➝ $90.00High
4/22/2022SVB LeerinkBoost Price TargetOutperform$100.00 ➝ $110.00High
4/22/2022Royal Bank of CanadaBoost Price TargetOutperform$89.00 ➝ $104.00High
4/22/2022Deutsche Bank AktiengesellschaftBoost Price TargetBuy$100.00 ➝ $110.00High
4/22/2022CitigroupBoost Price TargetBuy$96.00 ➝ $110.00High
4/22/2022BarclaysBoost Price TargetOverweight$99.00 ➝ $104.00High
4/14/2022SVB LeerinkReiterated RatingBuy$100.00N/A
4/7/2022Truist FinancialBoost Price Target$90.00 ➝ $100.00Low
3/28/2022Wells Fargo & CompanyInitiated CoverageOverweight$100.00Medium
3/7/2022Jefferies Financial GroupBoost Price TargetBuy$120.00 ➝ $125.00Low
3/3/2022MizuhoBoost Price TargetBuy$90.00 ➝ $103.00Medium
3/1/2022The Goldman Sachs GroupReiterated RatingBuy ➝ BuyHigh
2/10/2022UBS GroupUpgradeNeutral ➝ Buy$83.00 ➝ $111.00High
2/9/2022Credit Suisse GroupBoost Price TargetOutperform$109.00 ➝ $111.00High
2/9/2022Deutsche Bank AktiengesellschaftBoost Price TargetBuy$80.00 ➝ $100.00High
2/9/2022SVB LeerinkUpgradeMarket Perform ➝ Outperform$88.00 ➝ $100.00High
2/9/2022BarclaysBoost Price TargetOverweight$87.00 ➝ $99.00High
2/9/2022Truist FinancialUpgradeHold ➝ Buy$90.00High
1/20/2022Raymond JamesUpgradeOutperform ➝ Strong-Buy$105.00 ➝ $120.00Medium
1/7/2022SVB LeerinkBoost Price TargetMarket Perform$78.00 ➝ $88.00Medium
1/5/2022Truist FinancialBoost Price Target$78.00 ➝ $90.00High
12/21/2021BarclaysBoost Price TargetOverweight$81.00 ➝ $87.00High
11/10/2021MizuhoBoost Price TargetBuy$75.00 ➝ $90.00Low
11/9/2021StephensBoost Price TargetEqual Weight$77.00 ➝ $92.00Low
10/25/2021CitigroupBoost Price TargetBuy$88.00 ➝ $91.00Low
10/22/2021SVB LeerinkLower Price TargetMarket Perform$80.00 ➝ $78.00Medium
10/22/2021Truist FinancialBoost Price TargetHold$72.00 ➝ $78.00Low
10/22/2021Credit Suisse GroupBoost Price TargetOutperform$88.00 ➝ $95.00Low
10/13/2021Truist FinancialLower Price TargetHold$78.00 ➝ $72.00Low
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$80.00High
9/23/2021UBS GroupInitiated CoverageNeutral$83.00Medium
9/8/2021BarclaysBoost Price TargetOverweight$78.00 ➝ $79.00Low
8/12/2021BarclaysUpgradeEqual Weight ➝ Overweight$62.00 ➝ $77.00Medium
8/9/2021MizuhoBoost Price TargetBuy$70.00 ➝ $75.00Low
7/23/2021Credit Suisse GroupBoost Price TargetOutperform$71.00 ➝ $88.00Medium
7/23/2021CitigroupInitiated CoverageBuy$70.84Medium
7/23/2021Royal Bank of CanadaBoost Price TargetOutperform$78.00 ➝ $83.00Medium
7/23/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$69.00 ➝ $80.00Medium
7/9/2021Seaport Res PtnReiterated RatingBuyMedium
6/18/2021Jefferies Financial GroupReiterated RatingBuyHigh
5/5/2021MizuhoBoost Price TargetBuy$55.00 ➝ $70.00Low
5/3/2021The Goldman Sachs GroupInitiated CoverageBuyHigh
4/23/2021BarclaysBoost Price Target$55.00 ➝ $62.00High
4/22/2021Truist FinancialBoost Price Target$56.00 ➝ $60.00Medium
4/22/2021CitigroupBoost Price Target$58.00 ➝ $65.00High
4/22/2021Credit Suisse GroupBoost Price TargetOutperform$58.00 ➝ $71.00High
4/22/2021Royal Bank of CanadaBoost Price TargetOutperform$57.00 ➝ $66.00High
4/9/2021MizuhoBoost Price TargetBuy$48.00 ➝ $55.00Medium
2/11/2021CitigroupBoost Price Target$50.00 ➝ $58.00Low
2/11/2021Credit Suisse GroupBoost Price TargetOutperform$52.00 ➝ $58.00Low
1/21/2021UBS GroupBoost Price TargetPositive ➝ Buy$37.00 ➝ $60.00High
1/14/2021Raymond JamesBoost Price TargetOutperform$55.00 ➝ $60.00High
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$27.00 ➝ $60.00Low
1/5/2021Bank of AmericaUpgradeNeutral ➝ Buy$45.00 ➝ $50.00N/A
12/18/2020MizuhoBoost Price TargetBuy$32.00 ➝ $48.00Medium
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyMedium
12/11/2020Smith Barney CitigroupBoost Price Target$33.00 ➝ $50.00High
12/11/2020Credit Suisse GroupBoost Price TargetOutperform$39.00 ➝ $48.00Medium
12/11/2020BarclaysBoost Price TargetEqual Weight$28.00 ➝ $46.00High
11/11/2020Piper SandlerBoost Price TargetNeutral$31.00 ➝ $36.00High
11/9/2020MizuhoBoost Price TargetBuy$30.00 ➝ $32.00High
10/22/2020Raymond JamesBoost Price TargetOutperform$40.00 ➝ $43.00High
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$28.00 ➝ $20.00High
9/4/2020Royal Bank of CanadaBoost Price Target$30.00 ➝ $35.00Low
8/14/2020Truist FinancialBoost Price Target$21.00 ➝ $30.00Medium
8/10/2020UBS GroupBoost Price TargetBuy$30.00 ➝ $35.00Low
8/5/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$25.00 ➝ $28.00High
8/4/2020Credit Suisse GroupReiterated RatingBuyHigh
6/11/2020UBS GroupLower Price TargetBuy$32.00 ➝ $30.00High
5/29/2020MizuhoLower Price TargetBuy$32.00 ➝ $30.00High
5/21/2020SunTrust BanksBoost Price TargetHold$22.00 ➝ $25.00Medium
5/20/2020CitigroupLower Price TargetBuy$35.00 ➝ $27.00High
5/14/2020UBS GroupLower Price TargetBuy$49.00 ➝ $32.00High
5/11/2020BarclaysBoost Price TargetEqual Weight$19.00 ➝ $22.00Low
5/6/2020Credit Suisse GroupReiterated RatingBuy$33.00Low
5/6/2020Wells Fargo & CompanyLower Price TargetEqual Weight$40.00 ➝ $32.00Low
5/6/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$31.00 ➝ $25.00High
4/13/2020SunTrust BanksBoost Price TargetHold$18.00 ➝ $22.00Low
4/13/2020Royal Bank of CanadaReiterated RatingBuy$26.00Medium
4/3/2020SunTrust BanksLower Price TargetHold$42.00 ➝ $18.00High
3/25/2020BarclaysReiterated RatingHold$19.00High
3/11/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$32.00 ➝ $39.00High
2/26/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$31.00 ➝ $32.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$20.00Low
12/20/2019JPMorgan Chase & Co.Boost Price TargetUnderweight$23.00 ➝ $31.00Medium
12/18/2019SunTrust BanksBoost Price TargetHold$31.00 ➝ $42.00Medium
12/9/2019UBS GroupUpgradeNeutral ➝ Buy$24.00 ➝ $53.00High
11/7/2019MizuhoReiterated RatingBuyLow
11/6/2019MizuhoBoost Price Target$30.00 ➝ $33.00Low
11/6/2019SunTrust BanksBoost Price TargetHold$24.00 ➝ $31.00High
11/6/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform$25.00 ➝ $36.00High
8/14/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$28.00 ➝ $28.00High
8/11/2019Royal Bank of CanadaReiterated RatingHold$26.00Medium
8/7/2019SunTrust BanksSet Price TargetHold$24.00Low
5/1/2019SunTrust BanksLower Price TargetHold$27.00High
4/17/2019BarclaysSet Price TargetHold$24.00Medium
2/27/2019Raymond JamesBoost Price Target$37.00 ➝ $47.00Medium
2/27/2019CitigroupBoost Price TargetBuy ➝ Buy$35.00 ➝ $37.00High
2/26/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$21.00 ➝ $30.00High
1/28/2019MizuhoReiterated RatingBuy$28.00Low
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$23.00Medium
1/6/2019BarclaysReiterated RatingHold$20.00High
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$20.00Low
12/17/2018Robert W. BairdDowngradeOutperform ➝ NeutralHigh
12/3/2018Raymond JamesReiterated RatingBuy$37.00High
11/15/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$26.00Low
11/7/2018Robert W. BairdReiterated RatingBuy$35.00High
11/7/2018BarclaysReiterated RatingHold$27.00High
8/14/2018BarclaysInitiated CoverageEqual Weight$35.00Low
8/10/2018JPMorgan Chase & Co.Boost Price TargetUnderweight ➝ Underweight$22.00 ➝ $28.00Low
8/8/2018Piper Jaffray CompaniesReiterated RatingHold$34.00Medium
8/8/2018SunTrust BanksReiterated RatingHold$35.00Medium
8/7/2018MizuhoSet Price TargetBuy$36.00Medium
7/23/2018CitigroupBoost Price TargetBuy ➝ Buy$37.00 ➝ $44.00High
6/29/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$28.00 ➝ $38.00Medium
5/9/2018MizuhoReiterated RatingBuy$35.00Medium
5/8/2018CitigroupBoost Price TargetBuy ➝ Buy$27.00 ➝ $37.00Low
5/4/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$27.00 ➝ $33.00Low
5/2/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$16.00 ➝ $24.00High
5/2/2018SVB LeerinkBoost Price TargetOutperform$30.00 ➝ $40.00High
4/17/2018SunTrust BanksReiterated RatingHold$27.00Low
3/22/2018MizuhoReiterated RatingBuy$29.00High
3/5/2018JPMorgan Chase & Co.Boost Price TargetUnderweight ➝ Underweight$15.00 ➝ $18.00Low
3/1/2018Piper Jaffray CompaniesReiterated RatingHold$21.00High
3/1/2018SunTrust BanksReiterated RatingHoldHigh
3/1/2018CitigroupBoost Price TargetBuy ➝ Buy$19.00 ➝ $27.00Low
2/28/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$15.00 ➝ $16.00Medium
2/28/2018Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $22.00High
2/28/2018Raymond JamesUpgradeMarket Perform ➝ Outperform$30.00High
2/27/2018Jefferies Financial GroupSet Price TargetBuy$23.00Low
1/30/2018Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$20.00High
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$15.00High
12/20/2017SVB LeerinkReiterated RatingBuy$27.00Low
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$14.00Medium
12/19/2017MizuhoBoost Price TargetNeutral$13.00 ➝ $15.00High
12/14/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$15.00Medium
12/12/2017CitigroupUpgradeNeutral ➝ BuyHigh
11/21/2017William BlairReiterated RatingMarket PerformN/A
11/13/2017Royal Bank of CanadaLower Price TargetSector Perform$19.00 ➝ $17.00N/A
11/10/2017MizuhoReiterated RatingNeutral ➝ HoldN/A
11/9/2017Morgan StanleyLower Price TargetEqual Weight$15.00 ➝ $14.00N/A
11/8/2017SVB LeerinkReiterated RatingOutperform$30.00 ➝ $25.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$15.00N/A
10/30/2017Jefferies Financial GroupSet Price TargetBuy$24.00 ➝ $20.00N/A
10/15/2017SunTrust BanksSet Price TargetHold$15.00N/A
9/28/2017Robert W. BairdReiterated RatingBuy$23.00High
9/25/2017Royal Bank of CanadaReiterated RatingHold$19.00High
9/21/2017Jefferies Financial GroupReiterated RatingBuy$24.00Low
9/14/2017MizuhoReiterated RatingNeutral$14.00Medium
9/14/2017CitigroupReiterated RatingHold$16.00Medium
9/1/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$24.00Low
8/24/2017Robert W. BairdReiterated RatingBuy$23.00Low
8/24/2017Royal Bank of CanadaReiterated RatingHold$25.00Low
8/20/2017MizuhoReiterated RatingNeutral$14.00High
8/20/2017SVB LeerinkReiterated RatingOutperform$23.00 ➝ $30.00High
(Data available from 8/11/2017 forward)

News Sentiment Rating

0.40 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
1/13/2022
  • 2 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/12/2022
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/14/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/13/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/13/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/12/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/12/2022
  • 9 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
8/11/2022

Current Sentiment

  • 9 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Tenet Healthcare logo
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $66.49
Low: $65.70
High: $66.54

50 Day Range

MA: $59.16
Low: $50.62
High: $67.88

52 Week Range

Now: $66.49
Low: $50.37
High: $92.65

Volume

1,117 shs

Average Volume

1,205,831 shs

Market Capitalization

$7.17 billion

P/E Ratio

8.26

Dividend Yield

N/A

Beta

2.43

Frequently Asked Questions

What sell-side analysts currently cover shares of Tenet Healthcare?

The following Wall Street research analysts have issued stock ratings on Tenet Healthcare in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Loop Capital, Mizuho, Raymond James, Royal Bank of Canada, Stephens, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for THC.

What is the current price target for Tenet Healthcare?

16 Wall Street analysts have set twelve-month price targets for Tenet Healthcare in the last year. Their average twelve-month price target is $92.38, suggesting a possible upside of 38.9%. Jefferies Financial Group Inc. has the highest price target set, predicting THC will reach $125.00 in the next twelve months. Stephens has the lowest price target set, forecasting a price of $73.00 for Tenet Healthcare in the next year.
View the latest price targets for THC.

What is the current consensus analyst rating for Tenet Healthcare?

Tenet Healthcare currently has 1 hold rating, 13 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe THC will outperform the market and that investors should add to their positions of Tenet Healthcare.
View the latest ratings for THC.

What other companies compete with Tenet Healthcare?

How do I contact Tenet Healthcare's investor relations team?

Tenet Healthcare's physical mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company's listed phone number is (469) 893-2200 and its investor relations email address is [email protected] The official website for Tenet Healthcare is www.tenethealth.com. Learn More about contacing Tenet Healthcare investor relations.